TIDMGWP

RNS Number : 9985P

GW Pharmaceuticals PLC

24 November 2016

 
 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i) 
-------------------------------------------------- 
 
 
 
 1. Identity of the issuer or                                          GW Pharmaceuticals PLC 
  the underlying issuer 
  of existing shares to which 
  voting rights are 
  attached: (ii) 
-------------------------------------------------------------  ------------------------------------- 
 2 Reason for the notification (please tick the appropriate 
  box or boxes): 
---------------------------------------------------------------------------------------------------- 
 An acquisition or disposal of voting rights 
-----------------------------------------------------------------  --------------------------------- 
 An acquisition or disposal of qualifying financial 
  instruments which may result in the acquisition 
  of shares already issued to which voting rights 
  are attached 
-----------------------------------------------------------------  --------------------------------- 
 An acquisition or disposal of instruments with                                    x 
  similar economic effect to qualifying financial 
  instruments 
-----------------------------------------------------------------  --------------------------------- 
 An event changing the breakdown of voting rights 
-----------------------------------------------------------------  --------------------------------- 
 Other (please 
  specify): 
---------------------------------------------------------  ------  --------------------------------- 
 3. Full name of person(s)                                        The Goldman Sachs Group, Inc. 
  subject to the 
  notification obligation: 
  (iii) 
-----------------------------------------------------------  --------------------------------------- 
 4. Full name of shareholder(s)                                    Goldman Sachs International 
  (if different from 3.):(iv)                                          Goldman, Sachs & Co. 
                                                                  Goldman Sachs Asset Management, 
                                                                               L.P. 
-----------------------------------------------------------  --------------------------------------- 
 5. Date of the transaction                                              18 November 2016 
  and date on 
  which the threshold is 
  crossed or 
  reached: (v) 
-----------------------------------------------------------  --------------------------------------- 
 6. Date on which issuer                                                 22 November 2016 
  notified: 
-----------------------------------------------------------  --------------------------------------- 
 7. Threshold(s) that is/are                                                 Below 3% 
  crossed or 
  reached: (vi, vii) 
-----------------------------------------------------------  --------------------------------------- 
 
 
 
 8. Notified details: 
------------------------------------------------------------------------------------------------------------ 
 A: Voting rights attached to shares (viii, ix) 
------------------------------------------------------------------------------------------------------------ 
 Class/type        Situation previous              Resulting situation after the 
  of                to the triggering               triggering transaction 
  shares            transaction 
 
  if possible 
  using 
  the ISIN 
  CODE 
----------------  ------------------------------  ---------------------------------------------------------- 
                   Number          Number          Number    Number of                % of voting 
                   of              of              of         voting                   rights (x) 
                   Shares          Voting          shares     rights 
                                   Rights 
----------------  --------------  --------------  --------  -----------------------  ----------------------- 
                                                   Direct    Direct   Indirect        Direct   Indirect 
                                                             (xi)      (xii) 
----------------  --------------  --------------  --------  -------  --------------  -------  -------------- 
                                                                          Below                    Below 
   GB0030544687       94,532          94,532                                3%                       3% 
                  --------------  --------------  --------  -------  --------------  -------  -------------- 
 
 
 B: Qualifying Financial Instruments 
------------------------------------------------------------------------------------------------------------ 
 Resulting situation after the triggering transaction 
------------------------------------------------------------------------------------------------------------ 
 Type of           Expiration      Exercise/                 Number of voting         % of voting 
  financial         date            Conversion                rights that              rights 
  instrument        (xiii)          Period (xiv)              may be 
                                                              acquired if 
                                                              the 
                                                              instrument 
                                                              is 
                                                              exercised/ 
                                                              converted. 
----------------  --------------  ------------------------  -----------------------  ----------------------- 
                                                                    Below 3%                 Below 3% 
----------------  --------------  ------------------------  -----------------------  ----------------------- 
   C: Financial Instruments with similar economic effect 
     to Qualifying Financial Instruments 
     (xv, xvi) 
   ---------------------------------------------------------------------------------------- 
                     Resulting situation after the triggering transaction 
   ---------------------------------------------------------------------------------------- 
    Type of financial   Exercise   Expiration    Exercise/      Number        % of voting 
        instrument        price       date       Conversion    of voting      rights (xix, 
                                                   period        rights           xx) 
                                                               instrument 
                                                                 refers 
                                                                   to 
   ------------------  ---------  -----------  ------------  ------------  ---------------- 
                                                                            Nominal   Delta 
   ------------------  ---------  -----------  ------------  ------------  --------  ------ 
                                                                 Below                Below 
                                                                   3%                   3% 
   ------------------  ---------  -----------  ------------  ------------  --------  ------ 
------------------------------------------------------------------------------------------------------------ 
 Total (A+B+C) 
------------------------------------------------------------------------------------------------------------ 
 Number of voting rights                           Percentage of voting rights 
------------------------------------------------  ---------------------------------------------------------- 
                    Below 3%                                               Below 3% 
------------------------------------------------  ---------------------------------------------------------- 
 
 
 
 9. Chain of controlled undertakings through which the 
  voting rights and/or the 
  financial instruments are effectively held, if applicable: 
  (xxi) 
---------------------------------------------------------------------------------------- 
 
   N/A 
 
 Proxy Voting: 
---------------------------------------------------------------------------------------- 
 10. Name of the proxy holder:                                         N/A 
-------------------------------------------------------  ------------------------------- 
 11. Number of voting rights proxy                                     N/A 
  holder will cease 
  to hold: 
-------------------------------------------------------  ------------------------------- 
 12. Date on which proxy holder will                                   N/A 
  cease to hold 
  voting rights: 
-------------------------------------------------------  ------------------------------- 
 
                                                          General email contact: 
  13. Additional information:                              shareholderdisclosures@gs.com 
-------------------------------------------------------  ------------------------------- 
 14. Contact name:                                        Joanna Foley 
-------------------------------------------------------  ------------------------------- 
 
 15. Contact telephone number:                             +44 207 051 9996 
-------------------------------------------------------  -------------------------------

This information is provided by RNS

The company news service from the London Stock Exchange

END

HOLEAPFDAEAKFFF

(END) Dow Jones Newswires

November 24, 2016 02:30 ET (07:30 GMT)

Gw Pharmaceuticals (LSE:GWP)
Historical Stock Chart
From Nov 2024 to Dec 2024 Click Here for more Gw Pharmaceuticals Charts.
Gw Pharmaceuticals (LSE:GWP)
Historical Stock Chart
From Dec 2023 to Dec 2024 Click Here for more Gw Pharmaceuticals Charts.